How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Practice Management (PMS) Market
- By Deployment Mode: On-Premise, Cloud-Based, Hybrid
- By End User: Hospitals, Physician Practices, Ambulatory Surgical Centers, Diagnostic Laboratories, Dental Clinics
- By Functionality: Appointment Scheduling, Billing and Invoicing, Patient Registration, Claims Management, Reporting and Analytics, Electronic Health Records (EHR) Integration
- By Specialty: General Practice, Cardiology, Orthopedics, Pediatrics, Dermatology, Oncology
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - On-Premise leads By Deployment Mode at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.169 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.177 →
Full report · locked preview
Everything inside the Medical Practice Management (PMS) Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Deployment Mode 3
End User 5
Functionality 6
Specialty 6
Companies profiled
Cerner Corporation
Epic Systems Corporation
Allscripts Healthcare Solutions
McKesson Corporation
Athenahealth Inc.
NextGen Healthcare
eClinicalWorks
GE Healthcare
Meditech
Practice Fusion
Greenway Health
AdvancedMD
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Cerner Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Epic Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Allscripts Healthcare Solutions
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →McKesson Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Athenahealth Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →NextGen Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →eClinicalWorks
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →GE Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Meditech
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Practice Fusion
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Greenway Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →AdvancedMD
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Kareo
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →CareCloud
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →DrChrono
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,728M by 2033 · 9.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- On-Premise61.1
- Cloud-Based17.6
- Hybrid21.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$431.5M → $801.2M · 8.0%
Europe$300.8M → $568.4M · 8.3%
Asia Pacific$274.6M → $519.9M · 8.3%
Latin America$170.0M → $397.3M · 11.2%
Middle East and Africa$130.8M → $297.8M · 10.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.582026
9.602027
9.612028
9.612029
9.622030
9.632031
9.642032
9.672033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Cerner Corporation17.7
- Epic Systems Corporation24.0
- Allscripts Healthcare Solutions10.0
- McKesson Corporation7.7
- Athenahealth Inc.6.7
- NextGen Healthcare5.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Deployment Mode21.3%
End User16.3%
Functionality38.4%
Specialty24.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.0
- Europe22.0
- Asia Pacific20.1
- Latin America15.4
- Middle East and Africa11.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Cerner Corporation | 79 | 82 | 85 | 88 | 95 | 74 | 84 |
| Epic Systems Corporation | 84 | 92 | 84 | 81 | 77 | 75 | 82 |
| Allscripts Healthcare Solutions | 74 | 77 | 81 | 78 | 70 | 86 | 78 |
| McKesson Corporation | 58 | 60 | 57 | 61 | 60 | 58 | 59 |
| Athenahealth Inc. | 71 | 60 | 63 | 62 | 66 | 68 | 65 |
| NextGen Healthcare | 55 | 53 | 66 | 71 | 46 | 50 | 57 |
| eClinicalWorks | 49 | 52 | 40 | 54 | 62 | 61 | 53 |
| GE Healthcare | 38 | 36 | 41 | 48 | 55 | 54 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Cerner Corporation
- Epic Systems Corporation
- Allscripts Healthcare Solutions
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Cerner Corporation | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Epic Systems Corporation | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Allscripts Healthcare Solutions | − | ✓ | ✓ | ✓ | ✓ | ◐ |
| McKesson Corporation | − | ◐ | ◐ | − | ◐ | − |
| Athenahealth Inc. | ✓ | ◐ | − | − | ◐ | ✓ |
| NextGen Healthcare | ◐ | − | ◐ | ◐ | − | − |
| eClinicalWorks | − | − | − | ◐ | − | ◐ |
| GE Healthcare | − | − | − | ◐ | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Cerner Corporation84
2Epic Systems Corporation82
3Allscripts Healthcare Solutions78
4Athenahealth Inc.65
5McKesson Corporation59
6NextGen Healthcare57
7eClinicalWorks53
8GE Healthcare45
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Cerner CorporationEpic Systems CorporationAllscripts Healthcare Solutions
Contender3
Focused players with pockets of strength.
McKesson CorporationAthenahealth Inc.NextGen Healthcare
Niche2
Specialists in a single segment or region.
eClinicalWorksGE Healthcare
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Deployment Mode in North America, then scale across Medical Practice Management (PMS) Market — a $665M beachhead inside a $10.4B market.
Beachhead (SOM)$665Mobtainable near-term
Serviceable (SAM)$4.10Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
On-Premise
Best fit — highest urgency & budget in Deployment Mode.
Economic buyer80 fit
Cloud-Based
Strong fit — clear ROI and a fast path to value.
End user70 fit
Hybrid
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Deployment Mode in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Functionality
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve18%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Deployment Mode leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Practice Management (PMS) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified21%
Evaluation12%
Closed-won8%
$17.4KCAC
$78KLTV
4.5:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Practice Management (PMS) Market is a high-growth opportunity — $12.7B by 2033, compounding at 11.1%.
TAM · 2025$5.48Btoday
TAM · 2033$12.7Bforecast
CAGR11.1%2027–2033
Cumulative$77.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$12.7BTotal addressable market
SAM$4.66BServiceable available market
SOM$808MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.1% CAGR
Demand compounds through 2033, outpacing GDP across Deployment Mode.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Deployment Mode moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$12.7BLarge & growingTAM by 2033 at 11.1% CAGR
$4.66BServiceable nowreachable with today’s model
$808MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$9.91BBear7.2% CAGR
$12.7BBase11.1% CAGR
$16.3BBull14.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Practice Management (PMS) Market — a $3.67B market by 2033. Plan: grow share from 9.9% to 16.9%.
Market size · 2033$3.67Btotal addressable
Market CAGR4.7%2027–2033
Target share16.9%from 9.9% today
Revenue ambition$620Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.9% | 16.9% | On track |
| Revenue | $355M | $620M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 29.0% | 44.8% | Behind |
| Customer retention | 91.8% | 96.6% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Deployment Mode
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Deployment Mode share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $83M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Deployment Mode leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Practice Management (PMS) Market conversation — a $2.42B market you can size, segment and defend in minutes.
Market size · 2033$2.42Btotal opportunity
Growth9.6%CAGR to 2033
Addressable buyers1,028+accounts in scope
Typical ROI6.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Deployment Mode
Goal Grow share in Deployment Mode
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.2×return on cost, year one
< 2 mopayback period
$62K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Cerner CorporationEpic Systems CorporationAllscripts Healthcare SolutionsMcKesson CorporationAthenahealth Inc.NextGen HealthcareeClinicalWorksGE Healthcare+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Practice Management (PMS) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Practice Management (PMS) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Anti-Obesity Prescription Drugs Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportBrilinta Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportTicagrelor Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportOral Antiseptic Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportCoenzyme A Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportImmunocytokines Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportChildhood Vaccines Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportGlioblastoma Treatment Drugs Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportParenteral Drugs Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportFormula Fed Bovine Serum Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportJakinibs Market
Market size, share, segmentation and regional forecast.
$842M market · 2025 base year
View reportHairy Cell Leukemia Drugs Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.